ArticleThe Journal of infectious diseases2022

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection.

Hans P Verkerke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.